nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—SRD5A1—polycystic ovary syndrome	0.351	0.445	CbGaD
Levonorgestrel—PGR—polycystic ovary syndrome	0.127	0.161	CbGaD
Levonorgestrel—SHBG—polycystic ovary syndrome	0.119	0.151	CbGaD
Levonorgestrel—AR—polycystic ovary syndrome	0.104	0.132	CbGaD
Levonorgestrel—CYP19A1—polycystic ovary syndrome	0.0872	0.111	CbGaD
Levonorgestrel—CYP19A1—follicular fluid—polycystic ovary syndrome	0.0157	0.183	CbGeAlD
Levonorgestrel—PGR—corpus luteum—polycystic ovary syndrome	0.01	0.117	CbGeAlD
Levonorgestrel—CYP19A1—corpus luteum—polycystic ovary syndrome	0.00903	0.106	CbGeAlD
Levonorgestrel—PGR—ovarian follicle—polycystic ovary syndrome	0.00785	0.0919	CbGeAlD
Levonorgestrel—CYP19A1—ovarian follicle—polycystic ovary syndrome	0.00706	0.0827	CbGeAlD
Levonorgestrel—ESR1—ovarian follicle—polycystic ovary syndrome	0.00614	0.0719	CbGeAlD
Levonorgestrel—SRD5A1—adrenal gland—polycystic ovary syndrome	0.00191	0.0224	CbGeAlD
Levonorgestrel—Abdominal bloating—Metformin—polycystic ovary syndrome	0.00174	0.0765	CcSEcCtD
Levonorgestrel—SRD5A1—endocrine gland—polycystic ovary syndrome	0.00166	0.0194	CbGeAlD
Levonorgestrel—CYP3A4—urine—polycystic ovary syndrome	0.00143	0.0168	CbGeAlD
Levonorgestrel—Toothache—Metformin—polycystic ovary syndrome	0.00136	0.0599	CcSEcCtD
Levonorgestrel—Contusion—Metformin—polycystic ovary syndrome	0.000949	0.0418	CcSEcCtD
Levonorgestrel—SHBG—endometrium—polycystic ovary syndrome	0.000862	0.0101	CbGeAlD
Levonorgestrel—ESR1—embryo—polycystic ovary syndrome	0.00083	0.00972	CbGeAlD
Levonorgestrel—SHBG—uterus—polycystic ovary syndrome	0.000794	0.0093	CbGeAlD
Levonorgestrel—SHBG—pituitary gland—polycystic ovary syndrome	0.00078	0.00913	CbGeAlD
Levonorgestrel—SHBG—adipose tissue—polycystic ovary syndrome	0.000777	0.0091	CbGeAlD
Levonorgestrel—PGR—endometrium—polycystic ovary syndrome	0.000777	0.00909	CbGeAlD
Levonorgestrel—Lightheadedness—Metformin—polycystic ovary syndrome	0.000741	0.0326	CcSEcCtD
Levonorgestrel—PGR—uterus—polycystic ovary syndrome	0.000716	0.00838	CbGeAlD
Levonorgestrel—PGR—pituitary gland—polycystic ovary syndrome	0.000703	0.00823	CbGeAlD
Levonorgestrel—PGR—adipose tissue—polycystic ovary syndrome	0.0007	0.00819	CbGeAlD
Levonorgestrel—CYP19A1—endometrium—polycystic ovary syndrome	0.000699	0.00818	CbGeAlD
Levonorgestrel—SHBG—adrenal gland—polycystic ovary syndrome	0.000697	0.00816	CbGeAlD
Levonorgestrel—AR—adrenal cortex—polycystic ovary syndrome	0.000693	0.00811	CbGeAlD
Levonorgestrel—SHBG—female gonad—polycystic ovary syndrome	0.00065	0.00761	CbGeAlD
Levonorgestrel—SHBG—vagina—polycystic ovary syndrome	0.000646	0.00756	CbGeAlD
Levonorgestrel—CYP19A1—uterus—polycystic ovary syndrome	0.000644	0.00754	CbGeAlD
Levonorgestrel—CYP19A1—adipose tissue—polycystic ovary syndrome	0.00063	0.00737	CbGeAlD
Levonorgestrel—PGR—adrenal gland—polycystic ovary syndrome	0.000628	0.00735	CbGeAlD
Levonorgestrel—AR—endometrium—polycystic ovary syndrome	0.000619	0.00724	CbGeAlD
Levonorgestrel—ESR1—endometrium—polycystic ovary syndrome	0.000607	0.00711	CbGeAlD
Levonorgestrel—SHBG—endocrine gland—polycystic ovary syndrome	0.000604	0.00707	CbGeAlD
Levonorgestrel—Pain in extremity—Metformin—polycystic ovary syndrome	0.000601	0.0264	CcSEcCtD
Levonorgestrel—Migraine—Metformin—polycystic ovary syndrome	0.000592	0.026	CcSEcCtD
Levonorgestrel—PGR—female gonad—polycystic ovary syndrome	0.000585	0.00685	CbGeAlD
Levonorgestrel—PGR—vagina—polycystic ovary syndrome	0.000582	0.00681	CbGeAlD
Levonorgestrel—AR—uterus—polycystic ovary syndrome	0.00057	0.00667	CbGeAlD
Levonorgestrel—CYP19A1—adrenal gland—polycystic ovary syndrome	0.000565	0.00661	CbGeAlD
Levonorgestrel—AR—pituitary gland—polycystic ovary syndrome	0.00056	0.00655	CbGeAlD
Levonorgestrel—ESR1—uterus—polycystic ovary syndrome	0.00056	0.00655	CbGeAlD
Levonorgestrel—AR—adipose tissue—polycystic ovary syndrome	0.000558	0.00653	CbGeAlD
Levonorgestrel—ESR1—pituitary gland—polycystic ovary syndrome	0.00055	0.00643	CbGeAlD
Levonorgestrel—ESR1—adipose tissue—polycystic ovary syndrome	0.000547	0.00641	CbGeAlD
Levonorgestrel—PGR—endocrine gland—polycystic ovary syndrome	0.000544	0.00637	CbGeAlD
Levonorgestrel—Breast disorder—Metformin—polycystic ovary syndrome	0.000543	0.0239	CcSEcCtD
Levonorgestrel—CYP19A1—female gonad—polycystic ovary syndrome	0.000527	0.00617	CbGeAlD
Levonorgestrel—Abdominal distension—Metformin—polycystic ovary syndrome	0.000523	0.023	CcSEcCtD
Levonorgestrel—Influenza—Metformin—polycystic ovary syndrome	0.000519	0.0229	CcSEcCtD
Levonorgestrel—Sweating increased—Metformin—polycystic ovary syndrome	0.000506	0.0223	CcSEcCtD
Levonorgestrel—AR—adrenal gland—polycystic ovary syndrome	0.0005	0.00586	CbGeAlD
Levonorgestrel—ESR1—adrenal gland—polycystic ovary syndrome	0.000491	0.00575	CbGeAlD
Levonorgestrel—CYP19A1—endocrine gland—polycystic ovary syndrome	0.00049	0.00574	CbGeAlD
Levonorgestrel—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000483	0.0212	CcSEcCtD
Levonorgestrel—AR—female gonad—polycystic ovary syndrome	0.000466	0.00546	CbGeAlD
Levonorgestrel—AR—vagina—polycystic ovary syndrome	0.000464	0.00543	CbGeAlD
Levonorgestrel—Infestation NOS—Metformin—polycystic ovary syndrome	0.000463	0.0204	CcSEcCtD
Levonorgestrel—Infestation—Metformin—polycystic ovary syndrome	0.000463	0.0204	CcSEcCtD
Levonorgestrel—ESR1—female gonad—polycystic ovary syndrome	0.000458	0.00536	CbGeAlD
Levonorgestrel—ESR1—vagina—polycystic ovary syndrome	0.000455	0.00533	CbGeAlD
Levonorgestrel—AR—endocrine gland—polycystic ovary syndrome	0.000434	0.00508	CbGeAlD
Levonorgestrel—ESR1—endocrine gland—polycystic ovary syndrome	0.000426	0.00498	CbGeAlD
Levonorgestrel—Rhinitis—Metformin—polycystic ovary syndrome	0.000417	0.0183	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000414	0.0182	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000409	0.018	CcSEcCtD
Levonorgestrel—Eye disorder—Metformin—polycystic ovary syndrome	0.000389	0.0171	CcSEcCtD
Levonorgestrel—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000386	0.017	CcSEcCtD
Levonorgestrel—Immune system disorder—Metformin—polycystic ovary syndrome	0.000376	0.0165	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000375	0.0165	CcSEcCtD
Levonorgestrel—Malnutrition—Metformin—polycystic ovary syndrome	0.000362	0.0159	CcSEcCtD
Levonorgestrel—Erythema—Metformin—polycystic ovary syndrome	0.000362	0.0159	CcSEcCtD
Levonorgestrel—Flatulence—Metformin—polycystic ovary syndrome	0.000357	0.0157	CcSEcCtD
Levonorgestrel—Muscle spasms—Metformin—polycystic ovary syndrome	0.000348	0.0153	CcSEcCtD
Levonorgestrel—Ethynodiol—PGR—polycystic ovary syndrome	0.000347	0.0576	CrCbGaD
Levonorgestrel—Norelgestromin—PGR—polycystic ovary syndrome	0.000327	0.0544	CrCbGaD
Levonorgestrel—Allylestrenol—PGR—polycystic ovary syndrome	0.000327	0.0544	CrCbGaD
Levonorgestrel—Syncope—Metformin—polycystic ovary syndrome	0.000325	0.0143	CcSEcCtD
Levonorgestrel—Palpitations—Metformin—polycystic ovary syndrome	0.00032	0.0141	CcSEcCtD
Levonorgestrel—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000318	0.014	CcSEcCtD
Levonorgestrel—Desogestrel—PGR—polycystic ovary syndrome	0.000315	0.0524	CrCbGaD
Levonorgestrel—Hypertension—Metformin—polycystic ovary syndrome	0.000312	0.0138	CcSEcCtD
Levonorgestrel—Chest pain—Metformin—polycystic ovary syndrome	0.000308	0.0136	CcSEcCtD
Levonorgestrel—Myalgia—Metformin—polycystic ovary syndrome	0.000308	0.0136	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000306	0.0135	CcSEcCtD
Levonorgestrel—Discomfort—Metformin—polycystic ovary syndrome	0.000304	0.0134	CcSEcCtD
Levonorgestrel—Oedema—Metformin—polycystic ovary syndrome	0.000295	0.013	CcSEcCtD
Levonorgestrel—Norgestimate—PGR—polycystic ovary syndrome	0.000295	0.049	CrCbGaD
Levonorgestrel—Desogestrel—SHBG—polycystic ovary syndrome	0.000294	0.0489	CrCbGaD
Levonorgestrel—Infection—Metformin—polycystic ovary syndrome	0.000293	0.0129	CcSEcCtD
Levonorgestrel—Nandrolone phenpropionate—AR—polycystic ovary syndrome	0.000293	0.0488	CrCbGaD
Levonorgestrel—Shock—Metformin—polycystic ovary syndrome	0.000291	0.0128	CcSEcCtD
Levonorgestrel—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00029	0.0127	CcSEcCtD
Levonorgestrel—Skin disorder—Metformin—polycystic ovary syndrome	0.000287	0.0126	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000286	0.0126	CcSEcCtD
Levonorgestrel—Anorexia—Metformin—polycystic ovary syndrome	0.000282	0.0124	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000269	0.0118	CcSEcCtD
Levonorgestrel—Dyspnoea—Metformin—polycystic ovary syndrome	0.000263	0.0116	CcSEcCtD
Levonorgestrel—Somnolence—Metformin—polycystic ovary syndrome	0.000263	0.0116	CcSEcCtD
Levonorgestrel—Dyspepsia—Metformin—polycystic ovary syndrome	0.00026	0.0114	CcSEcCtD
Levonorgestrel—Decreased appetite—Metformin—polycystic ovary syndrome	0.000257	0.0113	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000255	0.0112	CcSEcCtD
Levonorgestrel—Etonogestrel—PGR—polycystic ovary syndrome	0.000255	0.0424	CrCbGaD
Levonorgestrel—Fatigue—Metformin—polycystic ovary syndrome	0.000255	0.0112	CcSEcCtD
Levonorgestrel—Constipation—Metformin—polycystic ovary syndrome	0.000253	0.0111	CcSEcCtD
Levonorgestrel—Testosterone Propionate—CYP17A1—polycystic ovary syndrome	0.00025	0.0416	CrCbGaD
Levonorgestrel—Nandrolone phenpropionate—CYP19A1—polycystic ovary syndrome	0.000246	0.0408	CrCbGaD
Levonorgestrel—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000242	0.0106	CcSEcCtD
Levonorgestrel—Etonogestrel—SHBG—polycystic ovary syndrome	0.000238	0.0396	CrCbGaD
Levonorgestrel—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000238	0.00278	CbGeAlD
Levonorgestrel—Urticaria—Metformin—polycystic ovary syndrome	0.000235	0.0103	CcSEcCtD
Levonorgestrel—Abdominal pain—Metformin—polycystic ovary syndrome	0.000234	0.0103	CcSEcCtD
Levonorgestrel—Nandrolone decanoate—AR—polycystic ovary syndrome	0.000222	0.0369	CrCbGaD
Levonorgestrel—Asthenia—Metformin—polycystic ovary syndrome	0.000212	0.00933	CcSEcCtD
Levonorgestrel—Pruritus—Metformin—polycystic ovary syndrome	0.000209	0.0092	CcSEcCtD
Levonorgestrel—Diarrhoea—Metformin—polycystic ovary syndrome	0.000202	0.00889	CcSEcCtD
Levonorgestrel—Dizziness—Metformin—polycystic ovary syndrome	0.000195	0.0086	CcSEcCtD
Levonorgestrel—Vomiting—Metformin—polycystic ovary syndrome	0.000188	0.00826	CcSEcCtD
Levonorgestrel—Rash—Metformin—polycystic ovary syndrome	0.000186	0.0082	CcSEcCtD
Levonorgestrel—Dermatitis—Metformin—polycystic ovary syndrome	0.000186	0.00819	CcSEcCtD
Levonorgestrel—Nandrolone decanoate—CYP19A1—polycystic ovary syndrome	0.000186	0.0309	CrCbGaD
Levonorgestrel—Headache—Metformin—polycystic ovary syndrome	0.000185	0.00814	CcSEcCtD
Levonorgestrel—Nausea—Metformin—polycystic ovary syndrome	0.000175	0.00772	CcSEcCtD
Levonorgestrel—Danazol—PGR—polycystic ovary syndrome	0.000164	0.0273	CrCbGaD
Levonorgestrel—Danazol—SHBG—polycystic ovary syndrome	0.000154	0.0255	CrCbGaD
Levonorgestrel—Testosterone Propionate—AR—polycystic ovary syndrome	0.000152	0.0253	CrCbGaD
Levonorgestrel—Norethindrone—PGR—polycystic ovary syndrome	0.000146	0.0243	CrCbGaD
Levonorgestrel—Ethinyl Estradiol—SHBG—polycystic ovary syndrome	0.000142	0.0236	CrCbGaD
Levonorgestrel—Norethindrone—SHBG—polycystic ovary syndrome	0.000137	0.0227	CrCbGaD
Levonorgestrel—Danazol—AR—polycystic ovary syndrome	0.000135	0.0224	CrCbGaD
Levonorgestrel—Methyltestosterone—SHBG—polycystic ovary syndrome	0.00013	0.0216	CrCbGaD
Levonorgestrel—Progesterone—CYP17A1—polycystic ovary syndrome	0.000115	0.0191	CrCbGaD
Levonorgestrel—Methyltestosterone—AR—polycystic ovary syndrome	0.000114	0.0189	CrCbGaD
Levonorgestrel—Danazol—CYP19A1—polycystic ovary syndrome	0.000113	0.0187	CrCbGaD
Levonorgestrel—Testosterone—CYP11A1—polycystic ovary syndrome	0.000107	0.0178	CrCbGaD
Levonorgestrel—Hydrocortisone—SHBG—polycystic ovary syndrome	9.77e-05	0.0162	CrCbGaD
Levonorgestrel—Methyltestosterone—CYP19A1—polycystic ovary syndrome	9.52e-05	0.0158	CrCbGaD
Levonorgestrel—Progesterone—PGR—polycystic ovary syndrome	8.52e-05	0.0142	CrCbGaD
Levonorgestrel—Progesterone—SHBG—polycystic ovary syndrome	7.96e-05	0.0132	CrCbGaD
Levonorgestrel—Testosterone—SHBG—polycystic ovary syndrome	7.53e-05	0.0125	CrCbGaD
Levonorgestrel—Progesterone—AR—polycystic ovary syndrome	6.98e-05	0.0116	CrCbGaD
Levonorgestrel—Testosterone—AR—polycystic ovary syndrome	6.6e-05	0.011	CrCbGaD
Levonorgestrel—Hydrocortisone—NR3C1—polycystic ovary syndrome	5.81e-05	0.00966	CrCbGaD
Levonorgestrel—Testosterone—CYP19A1—polycystic ovary syndrome	5.52e-05	0.00918	CrCbGaD
Levonorgestrel—Progesterone—NR3C1—polycystic ovary syndrome	4.74e-05	0.00787	CrCbGaD
Levonorgestrel—PGR—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	4.6e-05	0.000473	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	4.58e-05	0.00047	CbGpPWpGaD
Levonorgestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	4.58e-05	0.00047	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—LPCAT2—polycystic ovary syndrome	4.56e-05	0.000469	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SUOX—polycystic ovary syndrome	4.56e-05	0.000469	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	4.5e-05	0.000463	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—CYP1A1—polycystic ovary syndrome	4.47e-05	0.000459	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	4.36e-05	0.000448	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	4.35e-05	0.000447	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—IRS1—polycystic ovary syndrome	4.34e-05	0.000446	CbGpPWpGaD
Levonorgestrel—Progesterone—CYP1A1—polycystic ovary syndrome	4.3e-05	0.00715	CrCbGaD
Levonorgestrel—PGR—Signaling Pathways—PTGER3—polycystic ovary syndrome	4.25e-05	0.000436	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—LHCGR—polycystic ovary syndrome	4.25e-05	0.000436	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ISYNA1—polycystic ovary syndrome	4.24e-05	0.000436	CbGpPWpGaD
Levonorgestrel—CYP19A1—Biological oxidations—POMC—polycystic ovary syndrome	4.23e-05	0.000434	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	4.17e-05	0.000428	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—MTHFR—polycystic ovary syndrome	4.16e-05	0.000428	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—TEAD2—polycystic ovary syndrome	4.15e-05	0.000427	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	4.15e-05	0.000426	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	4.12e-05	0.000423	CbGpPWpGaD
Levonorgestrel—Testosterone—CYP1A1—polycystic ovary syndrome	4.06e-05	0.00676	CrCbGaD
Levonorgestrel—ESR1—Signaling by ERBB4—AKT2—polycystic ovary syndrome	4.02e-05	0.000413	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.97e-05	0.000408	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	3.94e-05	0.000405	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—IL6—polycystic ovary syndrome	3.87e-05	0.000398	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	3.87e-05	0.000398	CbGpPWpGaD
Levonorgestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	3.87e-05	0.000397	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	3.86e-05	0.000396	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ADRA1D—polycystic ovary syndrome	3.85e-05	0.000396	CbGpPWpGaD
Levonorgestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	3.84e-05	0.000395	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—RPL37A—polycystic ovary syndrome	3.84e-05	0.000395	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	3.79e-05	0.00039	CbGpPWpGaD
Levonorgestrel—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	3.79e-05	0.00039	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ADRA1B—polycystic ovary syndrome	3.75e-05	0.000385	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	3.67e-05	0.000377	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—INHBB—polycystic ovary syndrome	3.65e-05	0.000375	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—TEAD2—polycystic ovary syndrome	3.61e-05	0.00037	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AKR1C2—polycystic ovary syndrome	3.61e-05	0.00037	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—PGR—polycystic ovary syndrome	3.6e-05	0.00037	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	3.53e-05	0.000362	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.47e-05	0.000356	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	3.43e-05	0.000352	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FLT4—polycystic ovary syndrome	3.42e-05	0.000351	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.41e-05	0.000351	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.41e-05	0.00035	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—YAP1—polycystic ovary syndrome	3.38e-05	0.000347	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	3.38e-05	0.000347	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	3.38e-05	0.000347	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PPARG—polycystic ovary syndrome	3.38e-05	0.000347	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	3.35e-05	0.000344	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	3.34e-05	0.000343	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—POMC—polycystic ovary syndrome	3.33e-05	0.000342	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—INS—polycystic ovary syndrome	3.31e-05	0.00034	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	3.18e-05	0.000326	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	3.15e-05	0.000324	CbGpPWpGaD
Levonorgestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	3.12e-05	0.00032	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	3.11e-05	0.000319	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FSHR—polycystic ovary syndrome	3.11e-05	0.000319	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—IL6—polycystic ovary syndrome	3.09e-05	0.000318	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PNPLA2—polycystic ovary syndrome	3.02e-05	0.00031	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	2.99e-05	0.000307	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NPB—polycystic ovary syndrome	2.99e-05	0.000307	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—TNRC6B—polycystic ovary syndrome	2.98e-05	0.000306	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—RPL37A—polycystic ovary syndrome	2.96e-05	0.000304	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	2.95e-05	0.000303	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	2.94e-05	0.000302	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	2.92e-05	0.0003	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.92e-05	0.0003	CbGpPWpGaD
Levonorgestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	2.87e-05	0.000294	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SRD5A1—polycystic ovary syndrome	2.87e-05	0.000294	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.84e-05	0.000292	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.84e-05	0.000292	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—AR—polycystic ovary syndrome	2.8e-05	0.000288	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	2.79e-05	0.000287	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FST—polycystic ovary syndrome	2.77e-05	0.000284	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	2.75e-05	0.000283	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.74e-05	0.000281	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—STAR—polycystic ovary syndrome	2.73e-05	0.000281	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—LHB—polycystic ovary syndrome	2.7e-05	0.000278	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	2.7e-05	0.000277	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	2.69e-05	0.000276	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.64e-05	0.000271	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	2.64e-05	0.000271	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	2.6e-05	0.000267	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	2.59e-05	0.000267	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—YAP1—polycystic ovary syndrome	2.58e-05	0.000265	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	2.56e-05	0.000263	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.56e-05	0.000263	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SCT—polycystic ovary syndrome	2.53e-05	0.00026	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PTGER3—polycystic ovary syndrome	2.49e-05	0.000256	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LHCGR—polycystic ovary syndrome	2.49e-05	0.000256	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	2.45e-05	0.000251	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HMMR—polycystic ovary syndrome	2.44e-05	0.00025	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.42e-05	0.000248	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FGF18—polycystic ovary syndrome	2.37e-05	0.000244	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RBP4—polycystic ovary syndrome	2.35e-05	0.000242	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PTAFR—polycystic ovary syndrome	2.33e-05	0.000239	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HSD3B1—polycystic ovary syndrome	2.32e-05	0.000239	CbGpPWpGaD
Levonorgestrel—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	2.32e-05	0.000239	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	2.31e-05	0.000237	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.3e-05	0.000236	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—AR—polycystic ovary syndrome	2.3e-05	0.000236	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	2.28e-05	0.000234	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—TNRC6B—polycystic ovary syndrome	2.27e-05	0.000233	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	2.26e-05	0.000233	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	2.26e-05	0.000232	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PGR—polycystic ovary syndrome	2.25e-05	0.000231	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	2.2e-05	0.000226	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—YAP1—polycystic ovary syndrome	2.2e-05	0.000226	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.19e-05	0.000225	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.18e-05	0.000224	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GAB1—polycystic ovary syndrome	2.17e-05	0.000223	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—INHBB—polycystic ovary syndrome	2.14e-05	0.00022	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—LHB—polycystic ovary syndrome	2.12e-05	0.000218	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—INSR—polycystic ovary syndrome	2.07e-05	0.000213	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HSD3B2—polycystic ovary syndrome	2.07e-05	0.000213	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	2.05e-05	0.000211	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	2.05e-05	0.000211	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.02e-05	0.000208	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NCOR1—polycystic ovary syndrome	2.01e-05	0.000206	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AKR1C1—polycystic ovary syndrome	2.01e-05	0.000206	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PDE3B—polycystic ovary syndrome	2e-05	0.000206	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—YAP1—polycystic ovary syndrome	1.98e-05	0.000204	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.97e-05	0.000202	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.94e-05	0.000199	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NR3C1—polycystic ovary syndrome	1.86e-05	0.000191	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SULT2A1—polycystic ovary syndrome	1.85e-05	0.00019	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FSHR—polycystic ovary syndrome	1.82e-05	0.000187	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—IL6—polycystic ovary syndrome	1.82e-05	0.000187	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—RRM2—polycystic ovary syndrome	1.79e-05	0.000184	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PLAT—polycystic ovary syndrome	1.78e-05	0.000183	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GHRL—polycystic ovary syndrome	1.78e-05	0.000183	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	1.75e-05	0.00018	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—TNRC6B—polycystic ovary syndrome	1.75e-05	0.00018	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PGR—polycystic ovary syndrome	1.73e-05	0.000178	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—YAP1—polycystic ovary syndrome	1.72e-05	0.000177	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	1.71e-05	0.000176	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ATF1—polycystic ovary syndrome	1.7e-05	0.000175	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	1.67e-05	0.000171	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.66e-05	0.000171	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NAMPT—polycystic ovary syndrome	1.66e-05	0.00017	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	1.65e-05	0.00017	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.65e-05	0.000169	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP11A1—polycystic ovary syndrome	1.64e-05	0.000168	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	1.63e-05	0.000168	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FST—polycystic ovary syndrome	1.63e-05	0.000167	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.62e-05	0.000167	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADRB3—polycystic ovary syndrome	1.61e-05	0.000165	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LHB—polycystic ovary syndrome	1.59e-05	0.000163	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	1.58e-05	0.000162	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NGFR—polycystic ovary syndrome	1.57e-05	0.000161	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PRL—polycystic ovary syndrome	1.56e-05	0.00016	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GNRH1—polycystic ovary syndrome	1.55e-05	0.000159	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AKR1C3—polycystic ovary syndrome	1.54e-05	0.000159	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NCOR1—polycystic ovary syndrome	1.53e-05	0.000157	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP17A1—polycystic ovary syndrome	1.52e-05	0.000156	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.5e-05	0.000154	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SCT—polycystic ovary syndrome	1.49e-05	0.000153	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.48e-05	0.000152	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	1.46e-05	0.00015	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—PPARG—polycystic ovary syndrome	1.44e-05	0.000148	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.42e-05	0.000146	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NR3C1—polycystic ovary syndrome	1.41e-05	0.000145	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FGF18—polycystic ovary syndrome	1.39e-05	0.000143	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RBP4—polycystic ovary syndrome	1.38e-05	0.000142	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GNAS—polycystic ovary syndrome	1.37e-05	0.000141	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—AR—polycystic ovary syndrome	1.35e-05	0.000138	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	1.33e-05	0.000137	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	1.33e-05	0.000137	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—TH—polycystic ovary syndrome	1.32e-05	0.000135	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.3e-05	0.000134	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—SERPINE1—polycystic ovary syndrome	1.3e-05	0.000133	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—YAP1—polycystic ovary syndrome	1.29e-05	0.000133	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NRG1—polycystic ovary syndrome	1.28e-05	0.000132	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SLC2A4—polycystic ovary syndrome	1.28e-05	0.000131	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GAB1—polycystic ovary syndrome	1.27e-05	0.000131	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.24e-05	0.000127	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.23e-05	0.000127	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—INSR—polycystic ovary syndrome	1.22e-05	0.000125	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NCOR1—polycystic ovary syndrome	1.18e-05	0.000121	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.16e-05	0.000119	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.14e-05	0.000117	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PGR—polycystic ovary syndrome	1.13e-05	0.000116	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IRS2—polycystic ovary syndrome	1.1e-05	0.000113	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPARG—polycystic ovary syndrome	1.1e-05	0.000113	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NR3C1—polycystic ovary syndrome	1.09e-05	0.000112	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GNAS—polycystic ovary syndrome	1.07e-05	0.00011	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—LEP—polycystic ovary syndrome	1.07e-05	0.00011	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.05e-05	0.000108	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.05e-05	0.000108	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PLAT—polycystic ovary syndrome	1.05e-05	0.000108	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GHRL—polycystic ovary syndrome	1.05e-05	0.000108	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NCOR1—polycystic ovary syndrome	1.02e-05	0.000105	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ATF1—polycystic ovary syndrome	9.99e-06	0.000103	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—SERPINE1—polycystic ovary syndrome	9.87e-06	0.000101	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	9.74e-06	0.0001	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP1A1—polycystic ovary syndrome	9.7e-06	9.96e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IRS1—polycystic ovary syndrome	9.58e-06	9.84e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—POMC—polycystic ovary syndrome	9.22e-06	9.47e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NGFR—polycystic ovary syndrome	9.22e-06	9.47e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—INS—polycystic ovary syndrome	9.17e-06	9.42e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRL—polycystic ovary syndrome	9.14e-06	9.39e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—MTHFR—polycystic ovary syndrome	9.04e-06	9.29e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IGF1—polycystic ovary syndrome	8.87e-06	9.11e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKT2—polycystic ovary syndrome	8.86e-06	9.11e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	8.82e-06	9.06e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.67e-06	8.91e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPARG—polycystic ovary syndrome	8.44e-06	8.67e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.42e-06	8.65e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	8.36e-06	8.59e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GNAS—polycystic ovary syndrome	8.04e-06	8.26e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	7.98e-06	8.19e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.66e-06	7.87e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SERPINE1—polycystic ovary syndrome	7.6e-06	7.81e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NRG1—polycystic ovary syndrome	7.52e-06	7.72e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARG—polycystic ovary syndrome	7.33e-06	7.53e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—POMC—polycystic ovary syndrome	7.23e-06	7.43e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—INS—polycystic ovary syndrome	7.19e-06	7.39e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	7.11e-06	7.3e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	6.78e-06	6.97e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IRS2—polycystic ovary syndrome	6.44e-06	6.61e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LEP—polycystic ovary syndrome	6.3e-06	6.47e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	6.18e-06	6.35e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.04e-06	6.21e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	5.85e-06	6.01e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.79e-06	5.95e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IRS1—polycystic ovary syndrome	5.62e-06	5.77e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—POMC—polycystic ovary syndrome	5.41e-06	5.56e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	5.39e-06	5.53e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—INS—polycystic ovary syndrome	5.38e-06	5.53e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.22e-06	5.36e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IGF1—polycystic ovary syndrome	5.21e-06	5.35e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKT2—polycystic ovary syndrome	5.2e-06	5.34e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.03e-06	5.17e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.94e-06	5.08e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	4.83e-06	4.96e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	4.77e-06	4.9e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4.51e-06	4.63e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	4.44e-06	4.56e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6—polycystic ovary syndrome	4.01e-06	4.12e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.84e-06	3.94e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.73e-06	3.84e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.51e-06	3.61e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.4e-06	3.49e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.13e-06	3.22e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.99e-06	3.07e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.83e-06	2.91e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.64e-06	2.71e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6—polycystic ovary syndrome	2.35e-06	2.42e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.14e-06	2.2e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.11e-06	2.17e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.1e-06	2.16e-05	CbGpPWpGaD
